Back to results
US RE50,957 E1Granted
Molecular rheostat for cofactor balance
AssigneeThe Regents of the University of California
InventorsJames U. Bowie, Tyler P. Korman, Paul H. Opgenorth
Life of this patent
Estimating the term…
Abstract
The disclosure provides a metabolic pathway for producing a metabolite, the metabolic pathway having a co-factor regulatory system for cofactor utilization in the metabolic pathway.
Claims21
A recombinant, artificial or engineered metabolic pathway comprising a plurality of enzymatic steps, that converts a substrate to a product wherein the metabolic pathway comprises:
- a non-naturally occurring molecular rheostat system in which two distinct cofactor-dependent enzymatic pathways convert a first metabolite in the metabolic pathway glyceraldehyde-3-phosphate (G3P) to a downstream the second metabolite within the metabolic pathwayand wherein the distinct cofactor dependent enzymatic pathways produce different intermediate metabolites using a first distinct cofactor,
- wherein the first distinct enzymatic pathwayprovides an enzyme that directly converts the first metabolite to the downstream second metabolite converts glyceraldehyde-3-phosphate (G3P) and NADP+ to 3-phosphoglycerate (3PG) and NADPH, and
- wherein the second distinct enzymatic pathwayprovides a plurality of enzymes that converts the first metabolite to the downstream second metabolite converts glyceraldehyde-3-phosphate (G3P), NADP+, and free phosphate (Pi) to 1,3-biphosphoglycerate (1,3-BPG) and converts 1,3-bisphophoglycerate (1,3-BPG) and ADP to 3-phosphoglycerate and ATP,
- wherein the non-naturally occurring molecular rheostat alternates between or simultaneously uses the two distinct cofactor-dependent enzymatic pathways for the production of the downstream second metabolite depending upon the availability of a second distinct cofactor free phosphate.
1 more element
A recombinant polypeptide comprising a sequence that shares at least 95% sequence identity to SEQ ID NO:
- 6 and comprises a D34A/, a L35R/ mutations and a T36K mutation and has glyceraldehyde-3-phosphate dehydrogenase activity.
Dependencies are inferred from the claim text.